Prenetics Global Limited Warrant
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PRENW Company Description
Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
PRENW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PRENW Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PRENW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PRENW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of PRENW in WallStreetBets Daily Discussion
PRENW News
Recent insights relating to PRENW
CNBC Recommendations
Recent picks made for PRENW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PRENW
Corporate Flights
Flights by private jets registered to PRENW
Our Analysis